BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fernández-montero JV, Vispo E, Barreiro P, Mendoza C, Labarga P, Soriano V. Treatment of Hepatitis C in HIV Patients in the New Era of Direct-Acting Antivirals. Curr Hepatitis Rep 2013;12:269-75. [DOI: 10.1007/s11901-013-0179-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Radley A, Tait J, Dillon JF. DOT-C: A cluster randomised feasibility trial evaluating d irectly o bserved an t i-H C V therapy in a population receiving opioid substitute therapy from community pharmacy. International Journal of Drug Policy 2017;47:126-36. [DOI: 10.1016/j.drugpo.2017.05.042] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 8.6] [Reference Citation Analysis]
2 Birger R, Kouyos R, Dushoff J, Grenfell B. Modeling the effect of HIV coinfection on clearance and sustained virologic response during treatment for hepatitis C virus. Epidemics 2015;12:1-10. [PMID: 26342237 DOI: 10.1016/j.epidem.2015.04.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]